CKW Financial Group’s iShares Biotechnology ETF IBB Stock Holding History

CKW Financial Group’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-78	Closed	-$8K	–	181
2018 Q1	$8K	Buy	+78	New	+$8.65K	﹤0.01%	141
2016 Q3	–	Sell	-21	Closed	-$2K	–	175
2016 Q2	$2K	Buy	+21	New	+$1.88K	﹤0.01%	160

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

CKW Financial Group's IBB Position: Q2 2018 in Review

CKW Financial Group sold out of iShares Biotechnology ETF (IBB) in Q2 2018, closing a stake of 78 shares — an estimated $8K sold.

CKW Financial Group first reported a position in IBB in Q2 2016 and held it in 2 quarters. The position peaked at $8K in Q1 2018. 609 funds tracked by Wall St. Rank hold IBB as of Q2 2018.

CKW Financial Group reported no remaining iShares Biotechnology ETF position as of Q2 2018 after selling out during the quarter.
CKW Financial Group sold 78 iShares Biotechnology ETF shares in Q2 2018, an estimated $8K.
CKW Financial Group first reported a position in iShares Biotechnology ETF in Q2 2016 and held it in 2 quarters.
CKW Financial Group's iShares Biotechnology ETF position peaked at $8K in Q1 2018.
609 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2018.

Based on CKW Financial Group's 13F filing for Q2 2018, filed 20 Jul 2018.